India's Approved Stem Cell Therapy for Knee Osteoarthritis Begins Clinical Use in Tamil Nadu
Dr. Kamakshi Memorial Hospitals in Tamil Nadu has introduced India's approved allogeneic bone marrow-derived mesenchymal stem cell therapy for knee osteoarthritis (OA). This treatment targets patients with mild to moderate knee OA to preserve the natural knee and delay or avoid replacement surgery. Orthopedic surgeon Dr. Deepak Kumar KS emphasizes a knee-preservation-first approach, collaborating with Dr. Sathish Kumar Thangamani to offer this innovative, scientifically supported therapy alongside conventional treatments like medication and physiotherapy.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 40/100.
Outlets measured: thetribune, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 10 Sept, 10:55 am. Other outlets followed.